ArticleActa parasitologica2025
Comparing the Interactions of Trichomonas vaginalis/gallinae Legumain-Like Cysteine Protease 1 (LEGU-1) and Human Legumain (LGMN) Protein Sequences with Proton Pump Inhibitor Drugs (Lansoprazole, Omeprazole, and Esomeprazole) by Bioinformatics Analyses.
Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe flagellar parasite Trichomonas vaginalis is the main cause of trichomoniasis cases globally and is associated with a broad range of complications. Due to the diverse range of virulence factors participating in the attachment, proliferation and resistance of this pathogen, preventive and well-tolerated compounds are necessary. One of the virulence factors in T. vaginalis, the legumain-like cysteine protease LEGU-1 is of particular interest as a target due to its potential influence on trichomoniasis and tumor development in urogenital systems, as well as its closely related to the avian strain T. gallinae. Previous studies on antineoplastic proton pump inhibitors revealed they also have legumain (LGMN) inhibitory activities.
methodsTherefore, this study aimed to compare the molecular interactions of T. vaginalis/gallinae LEGU-1 and H. sapiens LGMN with proton pump inhibitor drugs (lansoprazole, omeprazole, and esomeprazole) through sequence analysis, 3D modeling, and molecular docking.
resultsAlthough sequence analyses revealed low homology between T. vaginalis/gallinae LEGU-1 and H. sapiens LGMN, secondary and 3D structural comparisons uncovered their structural conservation. Possible binding sites in all three proteins identified via CB-DOCK2 were compared to the previously described sites for LGMN, followed by targeted docking using Autodock Vina. Identification of amino acids mutually interacting with all three ligands by both programs revealed the overall conservation of the binding pockets. The variations in the number of amino acids within the binding sites for all three proteins displayed the variations in the binding energies for each ligand. Lansoprazole, omeprazole and esomeprazole were shown to bind T. vaginalis/gallinae LEGU-1 and H. sapiens LGMN, with lansoprazole having the highest binding energy.
conclusionConclusion Beyond our promising bioinformatics results, this study can guide further research on the development of alternative therapeutic methods against trichomoniasis and concomitant conditions.
Indexed as
Identifiers
41410717What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.